Infective Endocarditis (IE) Mortality Risk Score
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–10
- Moderate Risk10–25
- High Risk25–50
- Very High Risk50–100
The Infective Endocarditis (IE) Mortality Risk Score calculates predicting 6-month mortality in patients with infective endocarditis using validated clinical parameters. Key inputs include age category. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Predicts 6-month mortality in patients with infective endocarditis using validated clinical parameters. This risk stratification tool was developed from the International Collaboration on Endocarditis (ICE) Prospective Cohort Study and helps clinicians assess prognosis and guide treatment decisions in patients with definite infective endocarditis. The score incorporates host factors, IE characteristics, and complications to provide mortality risk prediction.
Clinical Indication
The Infective Endocarditis (IE) Mortality Risk Score is indicated for bedside clinical practice to support Predicts 6-month mortality in patients with infective endocarditis using validated clinical parameters. This risk stratification tool was developed from the International Collaboration on Endocarditis (ICE) Prospective Cohort Study and helps clinicians assess prognosis and guide treatment decisions in patients with definite infective endocarditis. The score incorporates host factors, IE characteristics, and complications to provide mortality risk prediction.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: Score ≥8 has sensitivity 86.7%, specificity 50.8%, NPV 86% for 6-month mortality.
Score = sum of all parameter points; Probability of 6-month mortality (%) = 100 × [1 / (1 + exp(-(2.416×score + 0.109×score² - 4.849)))]
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age_category | string | Yes | Patient age category. Older age associated with increased mortality risk |
| history_of_dialysis | string | Yes | History of chronic dialysis treatment. Dialysis patients have higher mortality risk |
| nosocomial_ie | string | Yes | Healthcare-associated infective endocarditis. Associated with worse outcomes |
| prosthetic_ie | string | Yes | Prosthetic valve infective endocarditis. Associated with higher mortality |
| symptoms_over_1_month | string | Yes | Symptoms present for more than 1 month before admission. Longer symptom duration may indicate lower acuity |
| staphylococcus_aureus | string | Yes | Staphylococcus aureus as causative pathogen. Associated with more aggressive disease |
| viridans_group_streptococci | string | Yes | Viridans group streptococci as causative pathogen. Generally associated with better prognosis |
| aortic_vegetation | string | Yes | Presence of aortic valve vegetation on echocardiography |
| mitral_vegetation | string | Yes | Presence of mitral valve vegetation on echocardiography |
| nyha_class_3_or_4_hf | string | Yes | NYHA Class 3 or 4 heart failure. Severe heart failure associated with poor prognosis |
| stroke | string | Yes | Stroke complication during IE episode. Major embolic complication |
| paravalvular_complication | string | Yes | Paravalvular complications (abscess, fistula, pseudoaneurysm). Indicates severe local tissue destruction |
| persistent_bacteremia | string | Yes | Persistent bacteremia despite appropriate antibiotic treatment. Indicates treatment failure |
| surgical_treatment | string | Yes | Surgical treatment performed during index hospitalization. Associated with improved survival when appropriately selected |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–10 | Low Risk | Mortality probability ≤10% |
| 10–25 | Moderate Risk | Mortality probability 10-25% |
| 25–50 | High Risk | Mortality probability 25-50% |
| 50–100 | Very High Risk | Mortality probability >50% |
Evidence-Based References (EBM)
- Gunes M, Gecmen C, Beker Evans M, et al. Validated Risk Score for Predicting 6-Month Mortality in Infective Endocarditis. J Am Heart Assoc. 2017 Apr 7;6(4):e003016. doi: 10.1161/JAHA.115.003016.DOI: 10.1161/JAHA.115.003016
- Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009 Mar 9;169(5):463-73. doi: 10.1001/archinternmed.2008.603.DOI: 10.1001/archinternmed.2008.603
- Cahill TJ, Baddour LM, Habib G, et al. Challenges in Infective Endocarditis. J Am Coll Cardiol. 2017 Jul 25;70(3):325-335. doi: 10.1016/j.jacc.2017.06.007.DOI: 10.1016/j.jacc.2017.06.007